Skip to content

    Health X Platform Limited

    HEALTHX
    Healthcare·17 Nov 2025
    Management Summary

    Sastasundar Ventures reported strong Q2 FY26 results with significant revenue and gross profit growth, driven by both its B2B and B2C segments. The company outlined a clear path to overall PAT positivity by FY26, supported by capital efficiency, strategic investments in AI and automation, and expansion plans. Management remains confident in achieving long-term revenue and margin targets despite being in a building phase.

    Highlights

    5

    • Revenue from operations for Q2 FY26 stood at INR307.9 crores, reflecting a 16.9% year-on-year and 10.6% quarter-on-quarter growth.

    • Gross profit reached INR22.9 crores, marking a 34.2% year-on-year and 9.8% quarter-on-quarter increase.

    • Gross profit margin expanded by 100 basis points to 7.5% in Q2 FY26, up from 6.5% in Q2 FY25.

    • Both core growth engines performed well, with RetailerShakti revenue at INR267.8 crores (up ~13% YoY) and Sastasundar B2C at INR39.4 crores (up ~60% YoY).

    • The company anticipates being PAT positive next year (FY26), driven by positive EBITDA from RetailerShakti and contribution margin from Sastasundar, supported by treasury income.

    Concerns

    2

    • Management acknowledged that the B2C growth, while strong, is still in a rebuilding phase, with the target of INR500 crores annual run rate in 18 months implying current lower scale.

    • The company is still in a 'building stage' and a 'start-up company,' with management noting that there might be 'a little bit hiccups maybe here and there' in its growth journey.

    What Changed1

    vs Q3 FY26

    Guidance items22 → 14 (-8)

    Key financials

    Single quarter

    03 metrics
    1. 01Revenue from Operations₹307.9 Cr+16.9%YoY
    2. 02Gross Profit₹22.9 Cr+34.2%YoY
    3. 03Gross Profit Margin7.5%

    Segment breakdown

    • RetailerShakti₹267.8 Cr87.2%
    • Sastasundar B2C₹39.4 Cr12.8%
    Donut· Share of Revenue

    Capital allocation

    4
    high confidence
    CategoryHeadline
    Capex

    Capex disclosed

    entirely through internal accruals and treasury income, without external capital

    Buyback

    ₹100 crores

    M&A

    Mitsubishi Corporation (part holding in Sastasundar Healthbuddy Limited)

    divestment · closed · Consideration ₹NaN (cash)

    Liquidity

    Cash ₹565 crores

    Net capital raise for Sastasundar Healthbuddy Limited was INR222 crores. Free treasury in Sastasundar Healthbuddy Limited is INR445 crores, and other subsidiary companies hold INR120 crores, totaling INR565 crores. The company is fully capitalized to fund its growth.

    Guidance & targets

    14
    CategoryTargetPriority
    Profitability
    RetailerShakti EBITDA
    breakeven
    		High
    Profitability
    RetailerShakti EBITDA Margin
    1%
    		High
    Profitability
    Sastasundar B2C Contribution Margin
    positive
    		High
    Profitability
    Sastasundar B2C EBITDA
    positive
    		Medium
    Profitability
    Overall Company PAT
    positive
    		High
    Profitability
    Overall EBITDA Margin
    4-5%
    		Medium
    Revenue
    Sastasundar B2C Annual Run Rate
    500 crores
    		High
    Revenue
    RetailerShakti Revenue
    4,000 crores
    		Medium
    Revenue
    Total Revenue
    6,000 crores
    		Medium
    Revenue
    Sales per HealthBuddy
    1 crore
    		High
    Volume
    RetailerShakti Retailer Count
    55,000
    		High
    Volume
    Health Buddy Count
    360
    		High
    Working Capital
    Working Capital as % of Sales
    3-4%
    		Medium
    Operations
    Retailer App Rollout
    fully integrated
    		High

    What to watch in Q3 FY26

    5

    RetailerShakti EBITDA Positivity

    next quarter
    CurrentRunning at breakeven
    TargetEBITDA positive

    Why it matters

    This is a key profitability milestone for the B2B segment, crucial for overall company PAT positivity.

    For RetailerShakti, we are already running at a breakeven, and this breakeven will further be strengthened by next quarter. So next quarter, it will be EBITDA positive RetailerShakti segment-wise.

    Risks & concerns

    2
    RiskSeverity

    Growth trajectory hiccups due to start-up/building stage

    Management noted that as a 'start-up company' in a 'building stage,' there might be 'a little bit hiccups' in the quarter-to-quarter or year-by-year growth trajectory. — Management acknowledged

    medium

    Customer adoption of new technology and AI tools

    Management stated that customer adoption of new technology is a 'very, very long-term process' and that people are 'habituated only by a long-term process,' implying a challenge in rapid user uptake for their AI-driven solutions. — Management acknowledged

    medium

    Q&A highlights

    8

    “For RetailerShakti, we are already running at a breakeven, and this breakeven will further be strengthened by next quarter. So next quarter, it will be EBITDA positive RetailerShakti segment-wise. And next year, we should be generating 1% EBITDA at RetailerShakti. And so this is what about RetailerShakti. Sastasundar we will be the margin positive company next year. Margin, I mean, contribution margin that covers all our variable cost. And we will continue to invest in Sastasundar for 2, 3 years. So we can say in the year '28, '29 financial year, we should be EBITDA positive in Sastasundar.”

    Clarifies the specific timelines for profitability for both B2B and B2C segments, indicating continued investment in B2C.

    asked by Vivek Gupta

    2 min read6 chapters

    Detailed Narrative

    01

    Q2 FY26 Financial Performance Highlights

    Sastasundar Ventures Limited reported a robust Q2 FY26, with revenue from operations reaching INR307.9 crores, marking a 16.9% year-on-year and 10.6% quarter-on-quarter increase. Gross profit also saw significant growth, up 34.2% YoY to INR22.9 crores, leading to a 100 basis points expansion in gross profit margin to 7.5%. The RetailerShakti B2B segment contributed INR267.8 crores (up ~13% YoY), while the Sastasundar B2C segment demonstrated strong growth with INR39.4 crores (up ~60% YoY).

    02

    Strategic Path to Profitability

    Management outlined a clear strategy for achieving profitability, targeting RetailerShakti to be EBITDA positive by the next quarter (Q3 FY26) and achieve a 1% EBITDA positive margin for the full FY26. The Sastasundar B2C segment is expected to become contribution margin positive next year. Overall, the company aims to be PAT positive by FY26, leveraging positive EBITDA from RetailerShakti, contribution margins from Sastasundar, and its treasury income to cover all costs.

    03

    Capital Efficiency and Funding Strategy

    The company emphasized its capital-efficient model, highlighting a net capital raise of INR222 crores for Sastasundar Healthbuddy Limited, which now holds INR445 crores in free treasury. Including other subsidiaries, the total treasury stands at INR565 crores, excluding a INR100 crore buyback to Mitsubishi Corporation. This strong liquidity position ensures the company is fully capitalized to fund its growth initiatives, including technology and warehouse expansion, without needing external capital for at least the next five years.

    04

    AI and Automation for Operational Excellence

    Sastasundar Ventures is heavily investing in AI and automation to enhance efficiency and scalability. Key applications include warehouse automation, which has tripled capacity with minimal investment and reduced manpower for picking and sorting. AI is also being deployed in call centers to halve manpower requirements and in coding processes. Future plans involve developing AI-driven counseling tools for customers and doctors to provide personalized health insights and improve service delivery.

    05

    Segment-Specific Growth and Expansion Plans

    RetailerShakti is projected to grow at over 30% compounding annually for the next 2-3 years, targeting INR4,000 crores in revenue by 2030, with plans to expand its retailer base from 40,000 to 55,000 by next year-end. Sastasundar B2C aims to achieve an annual run rate of INR500 crores within the next 18 months, supported by an increase in Health Buddies from 260 to 360 by March 2026, each expected to generate INR1 crore in annual sales. The company also plans to roll out a fully integrated retailer app by May/June 2026.

    06

    Corporate Structure Simplification and Long-term Vision

    The company has simplified its corporate structure by completing a buyback of Mitsubishi Corporation's stake, increasing its holding in Sastasundar Healthbuddy Limited to 78.89%. This move paves the way for a planned merger and demerger scheme with the holding company, to be presented to the Board by March 31, 2026. The long-term vision includes achieving INR6,000 crores in total revenue (INR4,000 crores from RetailerShakti and INR2,000 crores from Sastasundar B2C) with a 4-5% EBITDA margin by FY29/30.

    This is an AI-generated summary of a publicly available earnings call transcript. It is for informational purposes only and does not constitute investment advice, a recommendation, or an endorsement. inve.money is not a SEBI-registered investment advisor. Please consult a qualified financial advisor before making any investment decisions.